Atlas Trials

Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma

Clinical trial NCT02784015 · UNKNOWN

Trial details

NCT number
NCT02784015
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Unresectable Localized Soft Tissue Sarcoma
Start date
2016-05-01
Primary completion
2020-05-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.